“synthorx” Archives

in
Entry Author Date Location
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx 12/09/19 San Diego
San Diego Tallies 7 IPOs in Best Year for Market Debuts Since 2014 12/15/18 San Diego
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs 11/14/18 San Diego
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs 04/30/18 San Diego
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Synthorx Raises $10M to Expand Use of Synthetic DNA in Biologics 07/20/16 San Diego
Synthorx Obtains $10,000,000 Series B Financing 07/20/16 San Diego
12 San Diego Life Sciences Startups to Watch in 2016 02/09/16 San Diego
West Coast Biotech Roundup: Adaptive, Synthorx, USC v. UCSD, 23andMe 08/20/15 San Diego
Synthorx Makes Proteins Using Expanded Alphabet of Synthetic DNA 08/20/15 San Diego
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
Page 1 of 1